Ohr Pharmaceutical (Nasdaq: OHRP) announced that Jason S. Slakter, MD, has been appointed Chief Executive Officer, effective August 7, 2015 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE